Sepsis chronically in MARS: Systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis

Journal of Immunology

Volumn 189, Issue 9, 2012, Pages 4648-4656

  Osuchowski, Marcin F ^a,b   Craciun, Florin ^a   Weixelbaumer, Katrin M ^b   Duffy, Elizabeth R ^a   Remick, Daniel G ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EOTAXIN; EOTAXIN 2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; COMPOSITE CYTOKINE SCORE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DEATH; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOPATHOLOGY; MIXED ANTI INFLAMMATORY RESPONSE SYNDROME; MORTALITY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEPSIS; SURVIVAL; UPREGULATION;

ACUTE-PHASE REACTION; ANIMALS; CECUM; CHRONIC DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; LIGATION; MICE; MICE, INBRED ICR; PUNCTURES; SEPSIS; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 84867903811     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201806     Document Type: Article

References (64)

1. Vincent, J. L., Y. Sakr, C. L. Sprung, V. M. Ranieri, K. Reinhart, H. Gerlach, R. Moreno, J. Carlet, J. R. Le Gall, and D. Payen; Sepsis Occurrence in Acutely Ill Patients Investigators. 2006. Sepsis in European intensive care units: results of the SOAP study. Crit. Care Med. 34: 344-353. (Pubitemid 43145611)
2. Vincent, J. L. 2008. EPIC II: sepsis around the world. Minerva Anestesiol. 74: 293-296.
3. Bone, R. C. 1992. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268: 3452-3455. (Pubitemid 23002750)
4. Remick, D. G. 2003. Cytokine therapeutics for the treatment of sepsis: why has nothing worked? Curr. Pharm. Des. 9: 75-82. (Pubitemid 36131707)
5. Angus, D. C. 2011. The search for effective therapy for sepsis: back to the drawing board? JAMA 306: 2614-2615.
6. Martí-Carvajal, A. J., I. Solà, D. Lathyris, and A. F. Cardona. 2011. Human recombinant activated protein C for severe sepsis. Cochrane Database Syst. Rev. (4):CD004388.
7. Newton, S., Y. Ding, C. S. Chung, Y. Chen, J. L. Lomas-Neira, and A. Ayala. 2004. Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response. Surg. Infect. (Larchmt) 5: 375-383. (Pubitemid 40458363)
8. Osuchowski, M. F., K. Welch, J. Siddiqui, and D. G. Remick. 2006. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177: 1967-1974. (Pubitemid 44092537)
9. Boomer, J. S., K. To, K. C. Chang, O. Takasu, D. F. Osborne, A. H. Walton, T. L. Bricker, S. D. Jarman, II, D. Kreisel, A. S. Krupnick, et al. 2011. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306: 2594-2605.
10. Novotny, A. R., D. Reim, V. Assfalg, F. Altmayr, H. M. Friess, K. Emmanuel, and B. Holzmann. 2012. Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis. Immunobiology 217: 616-621.
11. Tamayo, E., A. Fernández, R. Almansa, E. Carrasco, M. Heredia, C. Lajo, L. Goncalves, J. I. Gómez-Herreras, R. O. de Lejarazu, and J. F. Bermejo-Martin. 2011. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur. Cytokine Netw. 22: 82-87.
12. Hotchkiss, R. S., C. M. Coopersmith, J. E. McDunn, and T. A. Ferguson. 2009. The sepsis seesaw: tilting toward immunosuppression. Nat. Med. 15: 496-497.
13. Stearns-Kurosawa, D. J., M. F. Osuchowski, C. Valentine, S. Kurosawa, and D. G. Remick. 2011. The pathogenesis of sepsis. Annu. Rev. Pathol. 6: 19-48.
14. Osuchowski, M. F., J. Connett, K. Welch, J. Granger, and D. G. Remick. 2009. Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit. Care Med. 37: 1567-1573.
15. Panacek, E. A., J. C. Marshall, T. E. Albertson, D. H. Johnson, S. Johnson, R. D. MacArthur, M. Miller, W. T. Barchuk, S. Fischkoff, M. Kaul, et al; Monoclonal Anti-TNF: a Randomized Controlled Sepsis Study Investigators. 2004. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit. Care Med. 32: 2173-2182. (Pubitemid 39491795)
16. van den Berg, J. W., M. van der Zee, R. W. de Bruin, C. van Holten-Neelen, J. Bastiaans, N. M. Nagtzaam, J. N. IJzermans, R. Benner, and W. A. Dik. 2011. Mild versus strong anti-inflammatory therapy during early sepsis in mice: a matter of life and death. Crit. Care Med. 39: 1275-1281.
17. Bahrami, S., L. Pelinka, A. Khadem, S. Maitzen, G. Hawa, M. van Griensven, and H. Redl. 2010. Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury. Crit. Care Med. 38: 161-166.
18. Opal, S. M. 2010. New perspectives on immunomodulatory therapy for bacteraemia and sepsis. Int. J. Antimicrob. Agents 36(Suppl. 2): S70-S73.
19. Ploder, M., L. Pelinka, C. Schmuckenschlager, B. Wessner, H. J. Ankersmit, W. Fuerst, H. Redl, E. Roth, and A. Spittler. 2006. Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock 25: 129-134.
20. Slotman, G. J. 2011. The systemic mediator-associated response test identifies patients in failed sepsis clinical trials among whom novel drugs reduce mortality. J. Trauma 71: 1406-1414.
21. Benjamim, C. F., C. M. Hogaboam, and S. L. Kunkel. 2004. The chronic consequences of severe sepsis. J. Leukoc. Biol. 75: 408-412. (Pubitemid 38316370)
22. Karlsson, S., E. Ruokonen, T. Varpula, T. I. Ala-Kokko, and V. Pettilä; Finnsepsis Study Group. 2009. Long-term outcome and quality-adjusted life years after severe sepsis. Crit. Care Med. 37: 1268-1274.
23. Winters, B. D., M. Eberlein, J. Leung, D. M. Needham, P. J. Pronovost, and J. E. Sevransky. 2010. Long-term mortality and quality of life in sepsis: a systematic review. Crit. Care Med. 38: 1276-1283.
24. Muenzer, J. T., C. G. Davis, K. Chang, R. E. Schmidt, W. M. Dunne, C. M. Coopersmith, and R. S. Hotchkiss. 2010. Characterization and modulation of the immunosuppressive phase of sepsis. Infect. Immun. 78: 1582-1592.
25. Döcke, W. D., F. Randow, U. Syrbe, D. Krausch, K. Asadullah, P. Reinke, H. D. Volk, and W. Kox. 1997. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med. 3: 678-681. (Pubitemid 27264980)
26. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, R. E. Schmieg, Jr., J. J. Hui, K. C. Chang, D. F. Osborne, B. D. Freeman, J. P. Cobb, T. G. Buchman, and I. E. Karl. 2001. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol. 166: 6952-6963. (Pubitemid 32467243)
27. Hotchkiss, R. S., and D. W. Nicholson. 2006. Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6: 813-822. (Pubitemid 44631650)
28. Ellaban, E., G. Bolgos, and D. Remick. 2004. Selective macrophage suppression during sepsis. Cell. Immunol. 231: 103-111. (Pubitemid 40775609)
29. Hubbard, W. J., M. Choudhry, M. G. Schwacha, J. D. Kerby, L. W. Rue, III, K. I. Bland, and I. H. Chaudry. 2005. Cecal ligation and puncture. Shock 24 (Suppl. 1): 52-57.
30. Jung, E., E. E. Perrone, Z. Liang, E. R. Breed, J. A. Dominguez, A. T. Clark, A. C. Fox, W. M. Dunne, E. M. Burd, A. B. Farris, et al. 2012. Cecal ligation and puncture followed by methicillin-resistant Staphylococcus aureus pneumonia increases mortality in mice and blunts production of local and systemic cytokines. Shock 37: 85-94.
31. Rittirsch, D., M. A. Flierl, B. A. Nadeau, D. E. Day, M. Huber-Lang, C. R. Mackay, F. S. Zetoune, N. P. Gerard, K. Cianflone, J. Köhl, et al. 2008. Functional roles for C5a receptors in sepsis. Nat. Med. 14: 551-557. (Pubitemid 351655216)
32. ves-Filho, J. C., F. Sonego, F. O. Souto, A. Freitas, W. A. Verri, Jr., M. Auxiliadora-Martins, A. Basile-Filho, A. N. McKenzie, D. Xu, F. Q. Cunha, and F. Y. Liew. 2010. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat. Med. 16: 708-712.
33. Volakli, E., C. Spies, A. Michalopoulos, A. B. Groeneveld, Y. Sakr, and J. L. Vincent. 2010. Infections of respiratory or abdominal origin in ICU patients: what are the differences? Crit. Care 14: R32.
34. Wichterman, K. A., A. E. Baue, and I. H. Chaudry. 1980. Sepsis and septic shock - a review of laboratory models and a proposal. J. Surg. Res. 29: 189-201. (Pubitemid 10039498)
35. Osuchowski, M. F., K. Welch, H. Yang, J. Siddiqui, and D. G. Remick. 2007. Chronic sepsis mortality characterized by an individualized inflammatory response. J. Immunol. 179: 623-630. (Pubitemid 46986580)
36. Xiao, H., J. Siddiqui, and D. G. Remick. 2006. Mechanisms of mortality in early and late sepsis. Infect. Immun. 74: 5227-5235. (Pubitemid 44300441)
37. Weixelbaumer, K. M., P. Raeven, H. Redl, M. van Griensven, S. Bahrami, and M. F. Osuchowski. 2010. Repetitive low-volume blood sampling method as a feasible monitoring tool in a mouse model of sepsis. Shock 34: 420-426.
38. Weixelbaumer, K. M., F. Craciun, S. Bahrami, H. Redl, D. G. Remick, and M. F. Osuchowski. 2009. Daily monitoring of immuno-inflammatory response - is it feasible in septic mice? Shock 31(Suppl. 1): 1-92.
39. Knight, P. R., A. Sreekumar, J. Siddiqui, B. Laxman, S. Copeland, A. Chinnaiyan, and D. G. Remick. 2004. Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis. Shock 21: 26-30.
40. Lichtenstern, C., T. Brenner, H. J. Bardenheuer, and M. A. Weigand. 2012. Predictors of survival in sepsis: what is the best inflammatory marker to measure? Curr. Opin. Infect. Dis. 25: 328-336.
41. Pierrakos, C., and J. L. Vincent. 2010. Sepsis biomarkers: a review. Crit. Care 14: R15.
42. Osuchowski, M. F., J. Siddiqui, S. Copeland, and D. G. Remick. 2005. Sequential ELISA to profile multiple cytokines from small volumes. J. Immunol. Methods 302: 172-181. (Pubitemid 41111884)
43. Nemzek, J. A., J. Siddiqui, and D. G. Remick. 2001. Development and optimization of cytokine ELISAs using commercial antibody pairs. J. Immunol. Methods 255: 149-157. (Pubitemid 32695391)
44. Drechsler, S., K. M. Weixelbaumer, H. Redl, M. van Griensven, S. Bahrami, and M. F. Osuchowski. 2011. Experimentally approaching the ICU: monitoring outcome-based responses in the two-hit mouse model of posttraumatic sepsis. J. Biomed. Biotechnol. 2011: 357926.
45. Remick, D. G., D. E. Newcomb, G. L. Bolgos, and D. R. Call. 2000. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13: 110-116.
46. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150. (Pubitemid 36056721)
47. Kellum, J. A., L. Kong, M. P. Fink, L. A. Weissfeld, D. M. Yealy, M. R. Pinsky, J. Fine, A. Krichevsky, R. L. Delude, and D. C. Angus; GenIMS Investigators. 2007. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch. Intern. Med. 167: 1655-1663. (Pubitemid 47280347)
48. Mera, S., D. Tatulescu, C. Cismaru, C. Bondor, A. Slavcovici, V. Zanc, D. Carstina, and M. Oltean. 2011. Multiplex cytokine profiling in patients with sepsis. APMIS 119: 155-163.
49. White, M., A. Mankan, M. W. Lawless, M. J. O'Dwyer, R. McManus, and T. Ryan. 2008. Mortality in humans with pneumonia and sepsis is related to an uncompensated anti-inflammatory response to infection. Arch. Intern. Med. 168: 1468-1469, author reply 1469.
50. Remick, D. G., G. R. Bolgos, J. Siddiqui, J. Shin, and J. A. Nemzek. 2002. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17: 463-467.
51. Bozza, F. A., J. I. Salluh, A. M. Japiassu, M. Soares, E. F. Assis, R. N. Gomes, M. T. Bozza, H. C. Castro-Faria-Neto, and P. T. Bozza. 2007. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit. Care 11: R49.
52. Andaluz-Ojeda, D., F. Bobillo, V. Iglesias, R. Almansa, L. Rico, F. Gandía, S. Resino, E. Tamayo, R. O. de Lejarazu, and J. F. Bermejo-Martin. 2012. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine 57: 332-336.
53. Oberholzer, A., S. M. Souza, S. K. Tschoeke, C. Oberholzer, A. Abouhamze, J. P. Pribble, and L. L. Moldawer. 2005. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23: 488-493. (Pubitemid 40677419)
54. Osuchowski, M., K. Welch, H. Yang, J. Siddiqui, and D. Remick. 2006. Sepsis: always in Mars. Shock.
55. Gogos, C., A. Kotsaki, A. Pelekanou, G. Giannikopoulos, I. Vaki, P. Maravitsa, S. Adamis, Z. Alexiou, G. Andrianopoulos, A. Antonopoulou, et al. 2010. Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit. Care 14: R96.
56. Cavaillon, J. M., M. Adib-Conquy, I. Cloëz-Tayarani, and C. Fitting. 2001. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. J. Endotoxin Res. 7: 85-93.
57. Cavaillon, J. M., and D. Annane. 2006. Compartmentalization of the inflammatory response in sepsis and SIRS. J. Endotoxin Res. 12: 151-170. (Pubitemid 47487521)
58. Tschaikowsky, K., M. Hedwig-Geissing, A. Schiele, F. Bremer, M. Schywalsky, and J. Schüttler. 2002. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: Longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit. Care Med. 30: 1015-1023. (Pubitemid 34508022)
59. Ayala, A., Z. K. Deol, D. L. Lehman, C. D. Herdon, and I. H. Chaudry. 1994. Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. J. Surg. Res. 56: 579-585. (Pubitemid 24222408)
60. Ayala, A., P. J. O'Neill, S. A. Uebele, C. D. Herdon, and I. H. Chaudry. 1997. Mechanism of splenic immunosuppression during sepsis: key role of Kupffer cell mediators. J. Trauma 42: 882-888. (Pubitemid 27258319)
61. Belikoff, B. G., S. Hatfield, P. Georgiev, A. Ohta, D. Lukashev, J. A. Buras, D. G. Remick, and M. Sitkovsky. 2011. A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice. J. Immunol. 186: 2444-2453.
62. Crowe, C. A., E. B. Kulstad, C. D. Mistry, and C. E. Kulstad. 2010. Comparison of severity of illness scoring systems in the prediction of hospital mortality in severe sepsis and septic shock. J. Emerg. Trauma Shock 3: 342-347.
63. Lee, C. C., S. Y. Chen, C. L. Tsai, S. C. Wu, W. C. Chiang, J. L. Wang, H. Y. Sun, S. C. Chen, W. J. Chen, and P. R. Hsueh. 2008. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock 29: 322-327.
64. Rhee, J. Y., K. T. Kwon, H. K. Ki, S. Y. Shin, D. S. Jung, D. R. Chung, B. C. Ha, K. R. Peck, and J. H. Song. 2009. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock 31: 146-150.